# NOCDURNA
> **NDA022517** · New Drug Application · Sponsor: FERRING PHARMS INC · Approved 2018-06-21
## Drug
- **FDA Application Number:** NDA022517
- **Application type:** New Drug Application
- **Brand name:** NOCDURNA
- **Generic name:** Desmopressin Acetate
- **Active ingredients:** DESMOPRESSIN ACETATE
- **Dosage form:** TABLET
- **Route:** SUBLINGUAL
- **Marketing status:** Discontinued
- **Sponsor:** FERRING PHARMS INC
- **First approval:** 2018-06-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022517)
---
*MORVS · CC0 1.0*